Virtual Inhibitory Quotient Predicts Response to Ritonavir Boosting of Indinavir-Based Therapy in Human Immunodeficiency Virus-Infected Patients with Ongoing Viremia

Depending on the degree of underlying resistance present, optimization of the pharmacokinetics of protease inhibitors may result in improved virologic suppression. Thirty-seven human immunodeficiency virus (HIV)-infected subjects who had chronic detectable viremia and who were receiving 800 mg of in...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Shulman, Nancy, Zolopa, Andrew, Havlir, Diane, Hsu, Ann, Renz, Cheryl, Boller, Sheila, Jiang, Ping, Rode, Richard, Gallant, Joel, Race, Elizabeth, Kempf, Dale J., Sun, Eugene
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2002
Assuntos:	Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC132776/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12435695/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.12.3907-3916.2002
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!